4//SEC Filing
Karam Sammy 4
Accession 0001415889-21-002195
CIK 0000001800other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 6:42 PM ET
Size
8.3 KB
Accession
0001415889-21-002195
Insider Transaction Report
Form 4
Karam Sammy
Senior Vice President
Transactions
- Exercise/Conversion
Common shares without par value
2021-04-27$75.90/sh+8,600$652,740→ 31,526 total - Sale
Common shares without par value
2021-04-27$122.00/sh−8,600$1,049,200→ 22,926 total - Exercise/Conversion
Option (right to buy)
2021-04-27−8,600→ 72,978 totalExercise: $75.90From: 2020-02-22Exp: 2029-02-21→ Common Shares (8,600 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001766718
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 6:42 PM ET
- Size
- 8.3 KB